Track multiple metrics beyond just scale weight to capture comprehensive progress or lack thereof
Rapid return of symptoms may indicate need for longer treatment duration or different approaches
For example, participants in the trials reported side effects that were generally consistent with previous studies, such as gastrointestinal symptoms, which are one of the main reasons that can lead to discontinuation of the drugs
for dual GLP-1/FGF21 agonist, BI-3006337 (YH-25724)
The analysis module on Halo was used to extract the cytoplasmic positivity for Melan-A, CD8, CD4, PD-L1, F4/80 and nuclear positivity of FOXP3 on all samples, stratifying the results on the basis of areas (that is, central tumour, tumour periphery and non-neoplastic/peritumoural)